Invitation
Welcome to the 3rd Annual Skin Basics for Primary Care Conference
We are pleased to invite Primary Care Practitioners to join us for the 3rd Annual Skin Basics for Primary Care (SBPC) Conference, taking place in September 2026 at the Toronto Marriott Markham. This full-day program is designed specifically to support primary care clinicians looking to strengthen their dermatology knowledge and confidence.
Our faculty of expert dermatologists will cover essential fundamentals, practical approaches, and updates on new and emerging treatments relevant to everyday practice. Join us for an engaging day of learning, discussion, and skill-building as we explore the core elements of dermatologic care together.
We look forward to welcoming you and supporting your continued excellence in patient care.
Your Co-Chairs,
Dr. Patrick Fleming, BSc(Nutrition), MSc(Community Health), MD, FRCPC
Assistant Professor of Medicine, University of Toronto
Dermatologist & Investigator, York Dermatology & Research Centre
Consultant Dermatologist, University Health Network
Dr. Kyle O. Lee, BMLSc, BMBS, MPH, CCFP
Academic Family Physician, Sumac Creek Health Centre, St. Michael’s Hospital
Assistant Professor, Department of Family & Community Medicine, University of Toronto
Who Should Attend
- General practitioners
- Family physicians
- Pediatricians
- Nurse practitioners
- Physician assistants
- Pharmacists
- Medical trainees
September 19, 2026
Toronto Marriott Markham Markham, ON
The 3rd Annual SBPC Conference will take place at the Toronto Marriott Markham, a modern, upscale hotel located in the heart of Downtown Markham. The hotel’s contemporary meeting facilities provide an ideal setting for the SBPC, offering a comfortable and professional environment for learning and collaboration. Free parking is available to delegates driving in for the day.
Guests who wish to stay onsite may book accommodations directly with the hotel. A dedicated hotel booking link is provided for your convenience.
Address: 170 Enterprise Boulevard Markham, Ontario
Program
Saturday, September 19, 2026
Continuing Professional Development: this conference is an unaccredited activity.
The 2026 Program is currently under construction. Please check back soon for updates.
Registration
Registration will open in January 2026.
All fees are in Canadian dollars and subject to taxes of 13% HST. Registration includes continental breakfast, lunch and parking.
| REGULAR – to Sept 12 |
LATE – Sept 12 – 19 |
|
| Primary Care Practitioner | $90.00 | $130.00 |
| Industry Sponsor* | $265.00 | $370.00 |
*Sponsoring companies may purchase up to 2 additional registrations for representatives.
Cancellations and Refunds Policy
All registration fees will be refunded less a $20.00 + applicable taxes for refund requests received on or prior to August 21, 2026. No refunds will be available for cancellations received on or after August 22, 2026. All requests must be received in writing. No telephone cancellations will be accepted. Submit cancellation letters to the Conference Secretariat at the email noted above.
Questions?
If you have any questions, please contact the Conference Secretariat by email at [email protected] or by phone at (604) 738-8600.
Sponsors
.
If you are interested in becoming a 2026 sponsor and would like the opportunity to showcase your latest dermatological innovations to local primary care providers via a sponsored program session, please contact us for more information: [email protected]
We are grateful to the following organizations for their support of the 3rd Annual Skin Basics for Primary Care 2026.
2026 DIAMOND SPONSORS
Arcutis Canada, Inc. is a wholly owned subsidiary of Arcutis Biotherapeutics. Arcutis Biotherapeutics champions innovation that addresses unmet patient needs—solving the everyday medical dermatology challenges that significantly impact patients and their families. With a passion for understanding what really matters to patients and healthcare providers, Arcutis leverages extensive dermatology development expertise to meaningfully advance the treatment of immune-mediated skin diseases. This expertise, along with Arcutis’ focus on biologically validated targets and its unique dermatology drug development platform prepares the company to tackle topical treatment innovation. Arcutis’ robust pipeline includes multiple development programs for a range of inflammatory dermatological conditions.
With the belief that patients deserve better than the current standard of care, the Arcutis team brings a sense of urgency, simplifying disease management and optimizing drug efficacy, safety, and tolerability to meet the needs of healthcare providers and patients. Arcutis has the potential to advance the standard of care for plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis.
2026 GOLD SPONSORS
Beiersdorf Canada is based in Saint-Laurent, Quebec. With our brands NIVEA, NIVEA MEN, Eucerin and Elastoplast we focus clearly on the needs of our consumers.
Beiersdorf Canada is one of more than 150 international affiliates of the cosmetics company Beiersdorf AG which is based in Hamburg, Germany. For over 130 years, we have dedicated ourselves to meeting our consumers’ individual needs and are considered to be the inventors of modern skin care. Our international success is founded on our research and development expertise, our innovative products, and our strong brands. Beiersdorf’s NIVEA is the world’s No.1 skin care brand*. Other names in its successful international brand portfolio include Eucerin, La Prairie, Labello, 8×4, and Hansaplast. Subsidiary tesa SE is one of the world’s leading producers of self-adhesive products and system solutions for industry, craft businesses, and consumers.
Sanofi and Regeneron are collaborating in the field of dermatology to transform the lives of patients with inflammatory skin diseases. This strategic partnership combines Regeneron’s scientific expertise in monoclonal antibodies with Sanofi’s global development and commercialization capabilities. Together, they have developed Dupixent, an innovative treatment that specifically targets type 2 inflammatory pathways involved in several dermatological conditions. Their commitment to ongoing research and therapeutic innovation aims to address the unmet needs of patients suffering from chronic dermatological diseases and improve their quality of life.
2026 SILVER SPONSORS
